NCT05423431View on ClinicalTrials.gov

Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009)

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

November 9, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Prostate Cancer
Interventions
OTHER

Observation

Assessment of rectal dosimetry change from pre-insertion to post-insertion in subjects with prostate cancer who have undergone radiotherapy with a hydrogel spacer.

Trial Locations (1)

111042

"Advanced Radiation Centers of New York (ARC)", Lake Success

Sponsors

Lead Sponsor

BioProtect
All Listed Sponsors
lead

BioProtect

INDUSTRY